Comparison of Skin and Blood Disease Burden in Patients with Cutaneous T-Cell Lymphoma
Cancers · 18.11.2026 · 18 (22) · 3685
DOI: 10.3390/cancers18223685 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 18.11.2026. Verfasst von Payton F. Trimark und 3 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Total body surface area (T) and blood (B) staging for cutaneous T-cell lymphoma (CTCL) are associated with disease progression and survival rates. However, the quantitative relationship between skin and blood disease burden in CTCL remains understudied.
Methods
This retrospective study assesses total body surface area (TBSA) compared with several quantitative flow cytometry metrics and peripheral blood morphology in 322 patients from 1 January 2012, to 31 December 2021. Sub-analyses also compare the estimated marginal mean TBSA between B stages; between qualitative determinations of blood abnormality by flow cytometry; and between qualitative determinations of blood abnormality by peripheral blood morphology. Lastly, we analyze the association between blood staging by 2007 and 2022 criteria.
Results
All possible combinations of T and B stages were represented in the cohort, except for T0-B2. TBSA was significantly but weakly associated with all flow cytometry and peripheral blood morphology metrics except the CD4:CD8 ratio. The estimated marginal mean TBSA was higher for B2 and B1 than the B0 stage but did not differ significantly between B2 and B1. The estimated marginal mean TBSA was higher for positive than for equivocal or negative qualitative determinations of blood disease burden by both flow cytometry and peripheral blood morphology. Comparing the 2007 and 2022 blood-staging flow cytometry criteria demonstrated only moderate correlation between the two classification criteria.
Conclusions
The limited association of TBSA with blood disease burden underscores the importance of assessing both skin and blood disease burden in patients being evaluated for CTCL to ensure accurate staging and prognostication.
Zitieren
APA
Trimark, P. F., Fu, L., Guitart, J., & Wolniak, K. (2026). Comparison of Skin and Blood Disease Burden in Patients with Cutaneous T-Cell Lymphoma. Cancers, 18(22), 3685. https://doi.org/10.3390/cancers18223685
Vancouver
Trimark PF, Fu L, Guitart J, Wolniak K. Comparison of Skin and Blood Disease Burden in Patients with Cutaneous T-Cell Lymphoma. Cancers. 2026;18(22):3685. doi:10.3390/cancers18223685
BibTeX
@article{Trimark2026,
author = {Trimark, Payton F. and Fu, Lucy and Guitart, Joan and Wolniak, Kristy},
title = {Comparison of Skin and Blood Disease Burden in Patients with Cutaneous T-Cell Lymphoma},
journal = {Cancers},
year = {2026},
volume = {18},
number = {22},
pages = {3685},
doi = {10.3390/cancers18223685}
}
EUVIMED